Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Label Change Proposal From GPhA, PhRMA Makes FDA Responsible For Timing

This article was originally published in The Pink Sheet Daily

Executive Summary

“Expedited Agency Review” idea would require an FDA review of proposed safety-related labeling changes before they are made and end the CBE-0 system brand companies already use and generics could be required to adopt.

Advertisement

Related Content

US FDA May Ask Congress For More Resources After Withdrawing Generic Label Reg
Will CBO Score CREATE Momentum For Generic Bill's Passage?
Will CBO Score CREATE Momentum For Generic Bill's Passage?
Generic, Brand Industry Codes Of Ethics Share Common Themes, Language
Generic, Brand Industry Codes Of Ethics Share Common Themes, Language
US FDA Looks To Proactively Update Old Generic Drug Labels Under Pilot
US FDA Looks To Proactively Update Old Generic Drug Labels Under Pilot
FDA Personnel Growth Looks To Have Plateaued For Drugs Program
Adverse Event Reports Rising, FDA Staffing Levels Not Keeping Pace
FDA Proposes Unilateral Generic Drug Label Changes, Signaling End To Liability Shield

Topics

Advertisement
UsernamePublicRestriction

Register

PS078185

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel